Assembly Biosciences ASMB
NASDAQ ASMB
$36.58 +0.45 (+1.25%)
As of: Sep 4, 2026 · 2:24 PM EDT

Assembly Biosciences (ASMB) Tax Provisions (2016 - 2025)

Assembly Biosciences (ASMB) posted quarterly Tax Provisions of -$76000.0 for Q4 2024, down 330.3% year-over-year from $33000.0 in Q1 2024, and down 118.72% quarter-over-quarter from $406000.0 in Q2 2024.

Analysis

Assembly Biosciences (ASMB) Tax Provisions (2016 - 2025) Analysis & Trends

Assembly Biosciences' Tax Provisions history runs 6 years deep, the most recent figure standing at -$76000.0 for Q4 2024.

  • In Q4 2024, Tax Provisions fell 330.3% year-over-year to -$76000.0; the TTM figure through Dec 2025 stood at -$76000.0 (down 120.94% YoY), while the FY2024 annual figure was $330000.0, up 900.0% from the prior year.
  • Tax Provisions for Q4 2024 stood at -$76000.0, down from $406000.0 in the prior quarter.
  • The five-year high for Tax Provisions was $406000.0 in Q2 2024, with the low at -$76000.0 in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Vertex Pharmaceuticals 138.78 Bn 130.92 Bn 2.84 Bn 292.00 Mn
2 Regeneron Pharmaceuticals 85.50 Bn 77.51 Bn 3.93 Bn 230.90 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -59.00 Mn
4 Moderna 58.06 Bn 52.92 Bn 52.00 Mn 15.00 Mn
5 Revolution Medicines 44.04 Bn 44.04 Bn - -
6 BeOne Medicines 40.04 Bn 34.94 Bn 1.53 Bn 75.45 Mn
7 Alnylam Pharmaceuticals 35.45 Bn 32.14 Bn 992.69 Mn 13.31 Mn
8 Royalty Pharma 28.41 Bn 27.57 Bn - -
9 Insmed 27.42 Bn 26.26 Bn 358.27 Mn 1.90 Mn
10 Assembly Biosciences 689.67 Mn 369.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.29 Mn
Dec 31, 2024 -76,000.00
Jun 30, 2024 406,000.00
Dec 31, 2023 33,000.00
Dec 31, 2019 -741,000.00
Sep 30, 2019 -15,000.00
Jun 30, 2019 -11,000.00
Mar 31, 2019 -7,000.00
Dec 31, 2018 1.14 Mn
Sep 30, 2018 -6,000.00
Jun 30, 2018 -34,000.00
Dec 31, 2017 -8.94 Mn
Sep 30, 2017 -35,903.00
Jun 30, 2017 -69,513.00
Dec 31, 2016 -618,000.00